1Rowbotham MC, Petersen KL. Zoster-associated pain and neural dysfunction.Pain 2001;93(1):1-5.
2Jung BF, Johnson RW, Griffin DR, et al.Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62(9):1545-51.
3Scott FT, Leedham-Green ME, Barrett-Muir WY, et al.A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 2003;70:S24-30.
4Wassilew S, Collaborative Brivudin PHN Study Group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind,multinational study. J Eur Acad Dermatol Venereol 2005;19(1):47-55.
5Whitley R J, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebocontrolled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.Ann Intern Med 1996;125(5):376-83.
6Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997;13(6):327-31.
7Pasqualucci A, Pasqualucci V, Galla F, et al.Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone.ActaAnaesthesiol Scand 2000;44(8):910-8.
8Trannoy E, Berger R, Hollander G, et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 2000;18(16):1700-6.
